Follow
Taran Gujral
Taran Gujral
Associate Professor, Fred Hutchinson Cancer Center
Verified email at fredhutch.org - Homepage
Title
Cited by
Cited by
Year
Vertical silicon nanowires as a universal platform for delivering biomolecules into living cells
AK Shalek, JT Robinson, ES Karp, JS Lee, DR Ahn, MH Yoon, A Sutton, ...
Proceedings of the National Academy of Sciences 107 (5), 1870-1875, 2010
6292010
A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis
TS Gujral, M Chan, L Peshkin, PK Sorger, MW Kirschner, G MacBeath
Cell 159 (4), 844-856, 2014
3622014
Molecular mechanisms of RET receptor–mediated oncogenesis in Multiple Endocrine Neoplasia 2B
TS Gujral, VK Singh, Z Jia, LM Mulligan
Cancer research 66 (22), 10741-10749, 2006
1122006
Exploiting polypharmacology for drug target deconvolution
TS Gujral, L Peshkin, MW Kirschner
Proc Natl Acad Sci U S A 111 (13), 5048-5, 2014
1042014
A novel RET kinase–β-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma
TS Gujral, W Van Veelen, DS Richardson, SM Myers, JA Meens, ...
Cancer Research 68 (5), 1338-1346, 2008
932008
Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays
TS Gujral, RL Karp, A Finski, M Chan, PE Schwartz, G MacBeath, ...
Oncogene 32 (29), 3470-3476, 2013
832013
Hippo pathway mediates resistance to cytotoxic drugs
TS Gujral, MW Kirschner
Proceedings of the National Academy of Sciences 114 (18), E3729-E3738, 2017
772017
A system-wide investigation of the dynamics of Wnt signaling reveals novel phases of transcriptional regulation
TS Gujral, G MacBeath
PloS one 5 (4), e10024, 2010
632010
Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery
R Sivakumar, M Chan, J Shin, N Nishida-Aoki, H Kenerson, ...
OncoImmunology, 1670019, 2019
622019
Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins
DS Richardson, TS Gujral, S Peng, SL Asa, LM Mulligan
Cancer research 69 (11), 4861-4869, 2009
612009
Emerging approaches to study cell–cell interactions in tumor microenvironment
N Nishida-Aoki, TS Gujral
Oncotarget 10 (7), 785, 2019
592019
A systematic family-wide investigation reveals that∼ 30% of mammalian PDZ domains engage in PDZ-PDZ interactions
BH Chang, TS Gujral, ES Karp, R BuKhalid, VP Grantcharova, ...
Chemistry & biology 18 (9), 1143-1152, 2011
592011
Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases
KM Sullivan, X Jiang, P Guha, C Lausted, JA Carter, C Hsu, KP Labadie, ...
Gut 72 (2), 325-337, 2023
562023
Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis
F Szulzewsky, S Arora, P Hoellerbauer, C King, E Nathan, M Chan, ...
Genes & development 34 (15-16), 1051-1064, 2020
542020
RET-mediated cell adhesion and migration require multiple integrin subunits
JG Cockburn, DS Richardson, TS Gujral, LM Mulligan
The Journal of Clinical Endocrinology & Metabolism 95 (11), E342-E346, 2010
492010
RET signaling in endocrine tumors: delving deeper into molecular mechanisms
AZ Lai, TS Gujral, LM Mulligan
Endocrine Pathology 18, 57-67, 2007
432007
Family-wide investigation of PDZ domain-mediated protein-protein interactions implicates β-catenin in maintaining the integrity of tight junctions
TS Gujral, ES Karp, M Chan, BH Chang, G MacBeath
Chemistry & biology 20 (6), 816-827, 2013
402013
Kinesin superfamily protein Kif26b links Wnt5a-Ror signaling to the control of cell and tissue behaviors in vertebrates
HHH Susman MW, Karuna EP, Kunz RC, Gujral TS, Cantú AV, Choi SS, Jong BY ...
Elife 26509, 2017
382017
Pharmaceutical compositions comprising RET inhibitors and methods for the treatment of cancer
TS Gujral, LM Mulligan, VK Singh
US Patent 8,629,135, 2014
372014
Microdissected “cuboids” for microfluidic drug testing of intact tissues
LF Horowitz, AD Rodriguez, A Au-Yeung, KW Bishop, LA Barner, ...
Lab on a Chip 21 (1), 122-142, 2021
362021
The system can't perform the operation now. Try again later.
Articles 1–20